-
effectivehealthcare-admin.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - This, in turn, may affect the perceived effectiveness or
safety of the product if the registry does … Drug Safety. 2015 January
1;38(1):13-5.
4. Elger B, Biller-Andorno N, Mauron A, et al. … http://www.fda.gov/downloads/Drugs/Drug
Safety/ucm089809.pdf. Accessed January
10, 2017.
21. … Direct-to-patient research: piloting a new
approach to understanding drug safety
during pregnancy. … Balancing the Interests of Patient Data
Protection and Medication Safety
Monitoring in a Public-Private
-
effectivehealthcare-admin.ahrq.gov/products/crohns-disease/research-protocol
December 01, 2019 - Our proposal will address these aims, as well as the safety and patient-reported outcomes representing … We aim to compare the effectiveness, safety and patient-reported outcomes representing quality of life … The patient-reported outcomes will also help patients and caregivers to take into consideration the implications … Objectives
We aim to compare the effectiveness, safety and patient-reported measures of individual … Because safety is an important issue and safety information may not always be reported by disease severity
-
effectivehealthcare-admin.ahrq.gov/products/insulin-blood-sugar-2010/research-protocol
December 01, 2019 - Home
Evidence Reports
Comparative Effectiveness and Safety … SHARE:
Comparative Effectiveness and Safety … However, the relative contribution of each of these factors to the disease course varies by patient. … rt-CGM differs from retrospective CGM in that it provides blood glucose feedback data to the patient … Internet Citation:
Research Protocol:
Comparative Effectiveness and Safety
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
February 01, 2012 - A disadvantage
of this over individual patient
randomization is that outcomes
for patients from a … A
disadvantage of this over
individual patient
randomization is that
outcomes for patients from a … post-ASCR
EFS 1 patient died of toxicity
at 3 months follow up. 5
patients were DOD at 5-
21 months … (70%),
partial remission in 1
patient (2%) and stable
disease in 13 patients
(28%). … with high-risk solid
tumors
Safety/Efficacy
study
30 patients (up
to 30 years of
age)
6/2006
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - Timing
We will include studies if patients have been on the medications for at least 3 months. … control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients … Pioglitazone and risk of cardiovascular events in
patients with type 2 diabetes mellitus: A meta-analysis … Inclusion and exclusion criteria
Population and condition
of interest
□ All studies included patients … We excluded
studies that evaluated only patients with type I diabetes, impaired glucose tolerance, metabolic
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/observational-research-scores_research.pdf
May 01, 2012 - about the outcomes, clinical effectiveness, safety, and appropriateness of health care items and
services … , 10 diagnostic groups for hospital discharges, 10
diagnostic groups for outpatient visits, and 10 indicators … A common question in pharmacoepidemiologic studies of drug safety is whether the risk
conferred by a … Pharmacoepidemiology and Drug Safety
2008;17:546-555. … Pharmacoepidemiol Drug
Safety 2005;14(7):465-76.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
March 13, 2012 - The FDA
addresses the safety and effectiveness of diagnostic tests and the quality of the design
and … Historically, the FDA has subjected test kits to premarket
review of safety and effectiveness but not … Clinical utility should reflect patient outcomes such as
improved survival. … result from both preanalytic factors [e.g., sample
preparation] as well as analytic factors [such as reagents … Patient advocacy Web sites for colon cancer will be searched.
-
effectivehealthcare-admin.ahrq.gov/products/cancer-anemia-update/research-protocol
December 01, 2019 - The 2006 CER revealed safety concerns for the erythropoietic stimulants as a class. … In an individual patient data meta-analysis of 13,933 patients in 53 trials treated with epoetin alfa … Study and Independent Patient Level Meta-Analysis Selection:
Results from study- and patient-level meta-analysis … Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data … Meta-analyses of safety data: a comparison of exact versus asymptotic methods.
-
effectivehealthcare-admin.ahrq.gov/products/retention-strategies-opioid-use-disorder/rapid-protocol
May 01, 2020 - EHC
The Evidence-based Practice Centers
The Scientific Resource Center
Registry of Patient … incarcerated)
Intervention/Exposure
Any strategy (or adjunct to MAT) that impacts the retention of patients … Patient Navigation Models for Lung Cancer. Rapid Evidence Product. … Human Development Indices and Indicators: 2018 Statistical Update . 2018. … Safety Practices and Ratings by a Technical Expert Panel, 2023-2024
Research Protocol
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
February 01, 2012 - • Patient insight into illness? … Web-based prioritization exercises allowed each stakeholder to distribute a limited
number of star-shaped indicators … some safety outcomes tend to be more homogenous across studies (e.g., weight gain). … Patient registries with linkages of patient-reported outcomes to clinical datasets (such as
claims or … Challenge that patients tend
to be reluctant to accept
randomization.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/nursing-staff-shortages-rapid-research-appendix-c.xlsx
January 01, 2024 - acuity tool
PE Pulmonary embolism
PP Preceptorship programmes
PSE Patient safety events
PSI Patient … Impact of Collaborative Nursing Care Delivery on Patient Safety Events in an Emergency Intensive Care … Journal of Patient Safety. 2024;20(4):252-8. doi: 10.1097/PTS.0000000000001215. PMID: 177467701. … Although the number of patients does not account for patient acuity, the decrease in the patients per … RN over 7 years indicated the importance of public reporting in improving patient safety.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
September 26, 2014 - for calibrating the
CGM (as applicable) and checking sensor performance as needed plus associated
reagents … Patients and
their diabetes care teams work to adjust patient insulin dosages using feedback from a … health
outcomes, citing safety concerns and limited efficacy data. … Summary of safety and effectiveness data
(SSED). MiniMed 530G system. P120010. … Efficacy and safety of insulin degludec in a
flexible dosing regimen vs insulin glargine in
patients
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
January 10, 2012 - To date, no comparative effectiveness review comparing the effectiveness and safety of
FDA-approved … with chronic plaque psoriasis, what is the comparative safety of systemic biologic
agents and systemic … followup),
patient baseline characteristics (including whether the patient is naïve to biologic therapy … We will also conduct
subgroup analyses based on the patient population evaluated, including patients … Efficacy and
safety results from the randomized controlled comparative study of adalimumab vs.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
June 01, 2015 - Treatments are aimed at symptomatic relief, but questions of safety and efficacy
remain. … However, other experts
thought the availability of a new IBS therapy with a seemingly good safety profile … Salix's TARGET 3 study examines the safety and
efficacy of repeat treatment with rifaximin 550 mg … -550
http://news.salix.com/press-release/salixs-target-3-study-examines-safety-and-efficacy-repeat-treatment-rifaximin … -550
http://news.salix.com/press-release/salixs-target-3-study-examines-safety-and-efficacy-repeat-treatment-rifaximin
-
effectivehealthcare-admin.ahrq.gov/products/depression-postpartum-screening/research-protocol
December 01, 2019 - FAQs
Home
Evidence Reports
Efficacy and Safety … SHARE:
Efficacy and Safety … There is high-quality evidence for effective treatment of patients who meet criteria for major depression … Project Timeline
Efficacy and Safety of Screening for Postpartum Depression
Nov 8, 2011 … 2017
Internet Citation:
Research Protocol:
Efficacy and Safety
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
September 01, 2010 - Over time, 73% of patients will have a
relapsing and remitting course, while only 10% of patients will … Our proposal will address these aims, as well as the safety and patient-reported
outcomes representing … We aim to compare the effectiveness, safety and patient-reported outcomes
representing quality of life … The patient-reported outcomes will also help patients and caregivers to take into
consideration the … Objectives
We aim to compare the effectiveness, safety and patient-reported measures of individual
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hro-protocol.pdf
January 01, 2023 - stakeholders, clinical specialists, experts in patient
safety issues, and a patient/consumer perspective … groups
6
Study Parameter Inclusion criteria Exclusion criteria
• Patients receiving
care … /products/prioritization-patient-safety-practices
https://effectivehealthcare.ahrq.gov/products/prioritization-patient-safety-practices … The TEP included 15 experts in patient safety with representa... … To accomplish that task, we will review AHRQ’s Patient Safety Networ...
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
April 01, 2011 - Summary of available data on patient
characteristics and response to prior medical
treatment have been … outcomes noted in question 1 include healing of erosive
esophagitis (EE), ambulatory pH, and other indicators … Commentator &
Affiliation
Section Comment Response
AstraZeneca esophagitis (EE), ambulatory pH, other indicators … comprising 11% of patients in the
trials.1 No overall differences were seen in the safety or effectiveness … The safety of
Thank you for your comments.
-
effectivehealthcare-admin.ahrq.gov/products/recombinant-factor-viia/clinician
March 01, 2020 - rFVIIa) in the hospital setting has increased despite limited comparative data on its effectiveness and safety … How is it being used, and what is the evidence of benefits and harms for treated patients? … Food and Drug Administration has approved rFVIIa for the treatment and prevention of bleeding in patients … results of this review are summarized here for use in your decisionmaking and in discussions with patients … Hemorrhage and Adult Cardiac Surgery
In-Hospital, Off-Label Use of rFVIIa
TE Events/Total Patients
-
effectivehealthcare-admin.ahrq.gov/products/copd-anticholinergic-medicines/research
January 01, 2020 - Therefore, each patient was given a 30 day immortal period following the switch. … homogeneous patient population. … Thus, there is still need to evaluate tiotropium safety in patient populations who are treatment naïve … Methodologic challenges to studying patient safety and comparative effectiveness. … Methodologic challenges to studying patient safety and comparative effectiveness.